No Data
Individual Investors Invested in Shanghai Kaibao Pharmaceutical CO.,Ltd (SZSE:300039) up 13% Last Week, Insiders Too Were Rewarded
shanghai kaibao pharmaceutical (300039.SZ) and its subsidiaries have a total of 91 pharmaceuticals included in the National Medical Insurance Catalogue.
Shanghai Kaibao (300039.SZ) announced that the company and its wholly-owned subsidiary Shanghai Kaibao Xinyi (Xinxiang) Pharmaceutical Co. ...
Shanghai Kaibao PharmaceuticalLtd (SZSE:300039) Sheds 5.6% This Week, as Yearly Returns Fall More in Line With Earnings Growth
Shanghai Kaibao: Report for the third quarter of 2024
Shanghai Kaibao Pharmaceutical (300039.SZ): The net income for the first three quarters was 0.217 billion yuan, a year-on-year increase of 10.68%.
Gelonghui on October 24th: shanghai kaibao pharmaceutical (300039.SZ) announced its third quarter report for 2024, with the company achieving revenue of 1.121 billion yuan in the first three quarters, a year-on-year decrease of 2.87%; net income attributable to shareholders of the listed company was 0.217 billion yuan, a year-on-year increase of 10.68%; net income attributable to shareholders of the listed company excluding non-recurring gains and losses was 0.212 billion yuan, a year-on-year increase of 11.93%; basic earnings per share was 0.2075 yuan.
Shanghai Kaibao Pharmaceutical CO.,Ltd's (SZSE:300039) Market Cap Rose CN¥397m Last Week; Retail Investors Who Hold 56% Profited and so Did Insiders
The Market Doesn't Like What It Sees From Shanghai Kaibao Pharmaceutical CO.,Ltd's (SZSE:300039) Earnings Yet
